Literature DB >> 24695227

Cancer: Damage prevention targeted.

Dan Dominissini1, Chuan He1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24695227     DOI： 10.1038/nature13221

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  20 in total

1.  Analysis of MTH1 gene function in mice with targeted mutagenesis.

Authors:  T Tsuzuki; A Egashira; S Kura
Journal:  Mutat Res       Date:  2001-06-02       Impact factor: 2.433

2.  Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence.

Authors:  P Rai; J J Young; D G A Burton; M G Giribaldi; T T Onder; R A Weinberg
Journal:  Oncogene       Date:  2010-11-15       Impact factor: 9.867

Review 3.  Redox control of the survival of healthy and diseased cells.

Authors:  Yuxing Zhang; Yanzhi Du; Weidong Le; Kankan Wang; Nelly Kieffer; Ji Zhang
Journal:  Antioxid Redox Signal       Date:  2011-06-11       Impact factor: 8.401

Review 4.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

5.  The oxidized forms of dATP are substrates for the human MutT homologue, the hMTH1 protein.

Authors:  K Fujikawa; H Kamiya; H Yakushiji; Y Fujii; Y Nakabeppu; H Kasai
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

6.  An oxidized purine nucleoside triphosphatase, MTH1, suppresses cell death caused by oxidative stress.

Authors:  Daisuke Yoshimura; Kunihiko Sakumi; Mizuki Ohno; Yasunari Sakai; Masato Furuichi; Shigenori Iwai; Yusaku Nakabeppu
Journal:  J Biol Chem       Date:  2003-07-10       Impact factor: 5.157

7.  MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.

Authors:  Helge Gad; Tobias Koolmeister; Ann-Sofie Jemth; Saeed Eshtad; Sylvain A Jacques; Cecilia E Ström; Linda M Svensson; Niklas Schultz; Thomas Lundbäck; Berglind Osk Einarsdottir; Aljona Saleh; Camilla Göktürk; Pawel Baranczewski; Richard Svensson; Ronnie P-A Berntsson; Robert Gustafsson; Kia Strömberg; Kumar Sanjiv; Marie-Caroline Jacques-Cordonnier; Matthieu Desroses; Anna-Lena Gustavsson; Roger Olofsson; Fredrik Johansson; Evert J Homan; Olga Loseva; Lars Bräutigam; Lars Johansson; Andreas Höglund; Anna Hagenkort; Therese Pham; Mikael Altun; Fabienne Z Gaugaz; Svante Vikingsson; Bastiaan Evers; Martin Henriksson; Karl S A Vallin; Olov A Wallner; Lars G J Hammarström; Elisee Wiita; Ingrid Almlöf; Christina Kalderén; Hanna Axelsson; Tatjana Djureinovic; Jordi Carreras Puigvert; Maria Häggblad; Fredrik Jeppsson; Ulf Martens; Cecilia Lundin; Bo Lundgren; Ingrid Granelli; Annika Jenmalm Jensen; Per Artursson; Jonas A Nilsson; Pål Stenmark; Martin Scobie; Ulrika Warpman Berglund; Thomas Helleday
Journal:  Nature       Date:  2014-04-02       Impact factor: 49.962

8.  Selective expansion of mitochondrial nucleoside triphosphate pools in antimetabolite-treated HeLa cells.

Authors:  R K Bestwick; G L Moffett; C K Mathews
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

9.  Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.

Authors:  D Ross Camidge; Yung-Jue Bang; Eunice L Kwak; A John Iafrate; Marileila Varella-Garcia; Stephen B Fox; Gregory J Riely; Benjamin Solomon; Sai-Hong I Ou; Dong-Wan Kim; Ravi Salgia; Panagiotis Fidias; Jeffrey A Engelman; Leena Gandhi; Pasi A Jänne; Daniel B Costa; Geoffrey I Shapiro; Patricia Lorusso; Katherine Ruffner; Patricia Stephenson; Yiyun Tang; Keith Wilner; Jeffrey W Clark; Alice T Shaw
Journal:  Lancet Oncol       Date:  2012-09-04       Impact factor: 41.316

10.  Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy.

Authors:  Kilian V M Huber; Eidarus Salah; Branka Radic; Manuela Gridling; Jonathan M Elkins; Alexey Stukalov; Ann-Sofie Jemth; Camilla Göktürk; Kumar Sanjiv; Kia Strömberg; Therese Pham; Ulrika Warpman Berglund; Jacques Colinge; Keiryn L Bennett; Joanna I Loizou; Thomas Helleday; Stefan Knapp; Giulio Superti-Furga
Journal:  Nature       Date:  2014-04-02       Impact factor: 49.962
View more
  3 in total

1.  Hypoxia-inducible factor-1 modulates upregulation of mutT homolog-1 in colorectal cancer.

Authors:  Yuan Qiu; Hong Zheng; Li-Hua Sun; Ke Peng; Wei-Dong Xiao; Hua Yang
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

Review 2.  Variations in brain DNA.

Authors:  Jesús Avila; Alberto Gómez-Ramos; Eduardo Soriano
Journal:  Front Aging Neurosci       Date:  2014-11-25       Impact factor: 5.750

3.  Profiling of ribonucleotides and deoxyribonucleotides pools in response to DNA damage and repair induced by methyl methanesulfonate in cancer and normal cells.

Authors:  Jian-Ru Guo; Zheng Li; Cai-Yun Wang; Christopher Wai Kei Lam; Qian-Qian Chen; Wei-Jia Zhang; Vincent Kam Wai Wong; Mei-Cun Yao; Wei Zhang
Journal:  Oncotarget       Date:  2017-10-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.